Overview of the global interventional image-guided systems market
Technavio’s market research analyst predicts the global interventional image-guided systems market to grow steadily at a CAGR of above 5% by 2021. One of the primary drivers for this market is the rising demand for interventional imaging in fractures and traumatic injuries. Fractures of the spine or hip caused by trauma or osteoporosis can be treated through surgeries that involve interventional image-guided systems for imaging. The number of cases of osteoporosis is high among the geriatric population. Osteoporosis can cause the bones to become porous, fragile, and weak, which make them susceptible to fractures. An unexpected fall can lead to hip, ankle, or spine fracture in the older population. In such cases, for the treatment and relieve pain, orthopedic specialists perform interventional imaging. Hip joint injections are injected through X-ray guided by fluoroscopy. For spine fracture, vertebroplasty, a non-invasive treatment, is performed by interventional radiologists using imaging guidance. This increasing adoption of non-invasive treatment among specialists, will, in turn, augment growth in the interventional image-guided systems market during the forecast period.
In terms of geography, the Americas accounted for the maximum market share during 2016 and will continue to dominate the market for the next few years. The US is the major revenue generator in the region. It has been observed that there is a rise of cardiovascular diseases (CVDs) in the region. The complexity of these diseases compels physicians to perform angiography and stenosis, these methods need interventional image-guided systems to operate effectively. Moreover, developed countries such as the US and Canada also have advanced medical infrastructure to improve the quality of life, offer better patient healthcare, and minimize hospital stays, which will further propel the market growth of the interventional image-guided systems market in the region.
Competitive landscape and key vendors
The global interventional image-guided systems market is highly fragmented due to the presence of several large- (Tier-1), medium- (Tier-2), and small-sized (Tier-3) companies. The advances in technology and product upgrade are expected to increase the competition among vendors. The established players are expected to compete on the basis of competitive pricing, product differentiation, capital support for product or technology upgrading, online and on-site servicing, a partnership with training clinics and governments, and exhibiting in medical expos/trade fairs.
Leading vendors in the market are –
- GE Healthcare
- Olympus
- Philips Healthcare
- Siemens Healthineers
- Toshiba Medical Systems
Other prominent vendors in the interventional image-guided systems market include Accuray, Accutome, ALPINION MEDICAL SYSTEMS, Analogic Corporation, ASAHI ROENTGEN, BenQ Medical Technology, BMV Technology, Brain Biosciences, Brainlab, Bruker, Capintec, Carestream Health, Cephasonics, CHISON, CMR Naviscan Corporation, ContextVision, CurveBeam, DDD-Diagnostic, Delphinus Medical Technologies, DENTSPLY SIRONA, Ecare, EOS imaging, Esaote, Fuel 3D Technologies, Gendex, Global Media Group, Guangzhou Yueshen Medical Equipment, Healcerion, Hologic, Imaging Sciences International, INSIGHTEC, Intelerad Medical Systems, INTRASENSE, J. Morita, Jiangsu TongRen Medical Electronic Technology, Konica Minolta, MedGyn, Mediso, Mindray, Mithil Scans, Mobisante, NanoVibronix, NeuroLogica, Neusoft, PLANMECA, Samsung Medison, Shimadzu, Shenzhen Bestman Instrument, SonoStar, Sofie Biosciences, SOREDEX (subsidiary of Danaher), St. Jude Medical, Sterne Medical, TOMTEC IMAGING SYSTEMS, Trivitron Healthcare, Viking Systems, Wuhan Tianyi Electronic, Xoran Technologies, Zhuhai Carelife Medical Technology, Zonare Medical Systems, and Zoncare Bio-Medical.
Segmentation by product and analysis of the interventional image-guided systems market
- Interventional CT image-guided systems
- Interventional X-ray image-guided systems
- Interventional MRI image-guided systems
- Interventional PET image-guided systems
- Interventional ultrasound image-guided systems
- Interventional endoscopy image-guided systems
- Interventional SPECT image-guided systems
During 2016, the interventional CT image-guided systems dominated the interventional image-guided systems market and accounted for a major part of the overall market share. Factors such as better image quality and the capability to take 360° pictures of internal organs are the key to the dominance of this segment in the global market.
Segmentation by application and analysis of the interventional image-guided systems market
- Cardiology
- Oncology
- Orthopedic and neurology
- Gastroenterology and urology
In this market study, analysts have estimated the cardiology segment to dominate the interventional image-guided systems market during the forecast period. The increasing number of cardiac cases are the key drivers for the escalation of demand for interventional image-guided systems in the interventional image-guided systems market.
Key questions answered in the report include
- What will the market size and the growth rate be in 2021?
- What are the key factors driving the global interventional image-guided systems market?
- What are the key market trends impacting the growth of the global interventional image-guided systems market?
- What are the challenges to market growth?
- Who are the key vendors in the global interventional image-guided systems market?
- What are the market opportunities and threats faced by the vendors in the global interventional image-guided systems market?
- Trending factors influencing the market shares of the Americas, APAC, and EMEA.
- What are the key outcomes of the five forces analysis of the global interventional image-guided systems market?
Technavio also offers customization on reports based on specific client requirement